REPROS THERAPEUTICS INC.: RPRX (Nasdaq Capital Market)
Enter your Email for a Free Trial: 
Free Trial
Form (Filer)  Received ( Period
SC 13D/A REPROS THERAPEUTICS INC.(EFFICACY CAPITAL, LTD.  02/09/10 
SC 13G/A REPROS THERAPEUTICS INC.(ENABLE CAPITAL MANAGEMENT, LLC  02/09/10 
8-K REPROS THERAPEUTICS INC.  02/08/10 (02/08/10) 
SC 13G/A REPROS THERAPEUTICS INC.(GROWTH EQUITY OPPORTUNITIES FUND, LLC  02/05/10 
4 REPROS THERAPEUTICS INC.(MASTERSON NOLA E  02/05/10 (02/04/10) 
4 REPROS THERAPEUTICS INC.(CAIN DANIEL F  02/05/10 (02/04/10) 
4 REPROS THERAPEUTICS INC.(FOURCROY JEAN L MD PHD MPH  02/05/10 (02/04/10) 
4 REPROS THERAPEUTICS INC.(WIEHLE RONALD  02/05/10 (12/02/09) 
4 REPROS THERAPEUTICS INC.(PODOLSKI JOSEPH  02/05/10 (12/02/09) 
8-K REPROS THERAPEUTICS INC.  02/02/10 (02/02/10) 
8-K REPROS THERAPEUTICS INC.  01/27/10 (01/27/10) 
8-K REPROS THERAPEUTICS INC.  01/26/10 (01/21/10) 
8-K REPROS THERAPEUTICS INC.  01/19/10 (01/12/10) 
8-K REPROS THERAPEUTICS INC.  01/11/10 (01/11/10) 
EFFECT REPROS THERAPEUTICS INC.  01/11/10 
EFFECT REPROS THERAPEUTICS INC.  01/08/10 
S-3/A REPROS THERAPEUTICS INC.  01/05/10 
SC 13G/A REPROS THERAPEUTICS INC.(BAM OPPORTUNITY FUND, L.P.  01/05/10 
SC 13D/A REPROS THERAPEUTICS INC.(EFFICACY CAPITAL, LTD.  12/31/09 
S-3/A REPROS THERAPEUTICS INC.  12/30/09 
 
 Results 1 - 20 of 563
     [1] 2 3 4 5 6 7 8 9 10   Next 10 Pages [ Show Next 20 Results ] 
Last Trade
Last Trade: 
$0.86  
Change: 
0.04 (4.88%)  
Trade Time: 
Feb 09  
Market Cap: 
$21.96M
Company People
View Officers and Directors and Other Key Individuals Mentioned in REPROS THERAPEUTICS INC. SEC Filings

Premium Content from Alacrastore.com